Biophytis presented its phase 3 protocol in the treatment of sarcopenia

22 Mar 2024 07:00 CET

Subscribe
Issuer

BIOPHYTIS

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1238665_240322_PR_ICFSR.pdf

Source

Biophytis

Provider

Les Echos

Company Name

BIOPHYTIS

ISIN

FR0012816825

Symbol

ALBPS

Market

Euronext Growth

Attachments

  • Original Link
  • Permalink

Disclaimer

Biophytis SA published this content on 22 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 March 2024 06:09:21 UTC.